Sfoglia per AUTORE
TARELLA C
Collezione AO Ordine Mauriziano

  

Items : 94

High-dose chemotherapy and autologous stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin Lymphoma in the era of PET-adapted strategies. in Leukemia & lymphoma / Leuk Lymphoma. 2024 Apr;65(4):460-471. doi: 10.1080/10428194.2023.2298273. Epub 2024 Jan 2.

2024
AO Ordine Mauriziano

Bagnardi V; Rambaldi A; Derenzini E; Sorio M; Gini G; Leotta S; Mulè A; Cocito F; Gottardi D; Rapezzi D; Lissandrini L; Tarella C; Marasco V; Sorasio R; Schiavotto C; Patti C; Romano A; Rossi A; Rusconi C; Frassoni S; Viviani S; Vanazzi A;

Long telomeres at baseline and male sex are main determinants of telomere loss following chemotherapy exposure in lymphoma patients. in Hematological oncology / Hematol Oncol. 2023 Aug;41(3):335-342. doi: 10.1002/hon.3118. Epub 2022 Dec 27.

2023
AO Ordine Mauriziano
ASL Torino 4
AOU Città della Salute di Torino
AOU Novara

Tarella C; Avvedimento EV; Pileri S; Gottardi D; Cignetti A; Risso A; Bruna R; Gueli A; Derenzini E;

AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia. in Cancer / Cancer. 2023 Apr 1;129(7):992-1004. doi: 10.1002/cncr.34608. Epub 2023 Jan 24.

2023
AOU Città della Salute di Torino
AO Cuneo
AO Ordine Mauriziano
AOU Novara

Martinelli G; Rossi G; Tarella C; Sciumè M; Marconi G; Abruzzese E; Cascavilla N; Rivellini F; Volpi R; Federico V; Gigli F; Roncoroni E; Romano A; Cardinali V; Nanni J; Maurillo L; Ferrara F; Lanza F; Cilloni D; Fianchi L; Lunghi M; Martini V; Molteni A; Gottardi M; Salutari P; Cairoli R; Borlenghi E; Manfra I; Basilico CM; et alii...

Prognostic Impact of Baseline Immunologic Profile in Aggressive B-cell non-Hodgkin's Lymphomas. in Mediterranean journal of hematology and infectious diseases / Mediterr J Hematol Infect Dis. 2021 Mar 1;13(1):e2021018. doi: 10.4084/MJHID.2021.018. eCollection 2

2021
AO Ordine Mauriziano

Saglio G; Radice T; Passerini R; Fiori S; Gottardi D; Pagan E; Bagnardi V; Sammassimo S; Cignetti A; Ceparano G; Ramadan S; Tarella C;

Early serum TARC reduction predicts prognosis in advanced-stage Hodgkin lymphoma patients treated with a PET-adapted strategy. in Hematological oncology / Hematol Oncol. 2020 Oct;38(4):501-508. doi: 10.1002/hon.2775. Epub 2020 Jul 30.

2020
AO Ordine Mauriziano
AO Cuneo

Gallamini A; Gianni AM; Corradini P; Galbiati M; Ferreri AJM; Farina L; Zanotti R; Cimminiello M; Tarella C; Gottardi D; Guidetti A; Sorasio R; Trentin L; Romano A; Patti C; Rossi A; Taverna F; Pavoni C; Mazzocchi A; Viviani S; Rambaldi A;

Influence of Donor and Recipient Gender on Telomere Maintenance after Umbilical Cord Blood Cell Transplantation: A Study by the Gruppo Italiano Trapianto Di Midollo Osseo. in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation / Biol Blood Marrow Transplant. 2019 Jul;25(7):1387-1394. doi: 10.1016/j.bbmt.2019.03.026. Epub 2019 M

2019
AO Ordine Mauriziano

Derenzini E; Risso A; Ruella M; Spatola T; Milone G; Pioltelli P; Iori AP; Santarone S; Bosi A; Rambaldi A; Bacigalupo AP; Arcese W; Tarella C;

Umbralisib monotherapy demonstrates efficacy and safety in patients with relapsed/refractory marginal zone lymphoma: A multicenter, open label, registration directed phase II study in Journal of Clinical Oncology

2019
AO Ordine Mauriziano

Reeves JA; Leslie LA; Chavez JC; Ghia P; Tarella C; Burke JM; Sharman JP; Kolibaba K; O'Connor OA; Ghosh N; Patten P; Fowler NH; Samaniego F; Jurczak W; Miskin HP; Sportelli P; Weiss MS; Cheah C; Zinzani PL; Lech-Maranda E;

Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2018 Feb 10;36(5):454-462. doi: 10.1200/JCO.2017.75.2543. Epub 2018 Jan 23.

2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AO Cuneo
AOU Città della Salute di Torino

Rambaldi A; Gianni AM; Pavoni C; Chauvie S; Bergesio F; Prosperini G; Chiaravalloti A; Gregianin M; Ficola U; Fallanca F; Biggi A; Avigdor A; Billio A; Miglino M; Viero P; Ferreri AJM; Gini G; Zanotti R; Parvis G; Schiavotto C; Cimminiello M; Corradini P; Gavarotti P; Gottardi D; Battistini R; Rapezzi D; Bolis S; Trentin L; La Nasa G; et alii...

Low circulating B lymphocytes in newly diagnosed follicular and diffuse large B cell lymphoma: Differences compared to normal subjects and possible prognostic role in Blood

2017
AO Ordine Mauriziano

Bruna R; Geuna M; Scalabrini DR; Cignetti A; Santoro N; Gottardi D; Passera R; Tarella C;

Molecular definition of activated B cell-like (ABC) DLBCL identifies patients who may benefit from front-line intensive R-HDS chemotherapy with ASCT in Blood

2017
AO Ordine Mauriziano

Melle F; Motta G; Fabbri M; Tabanelli V; Calleri A; Bruna R; Derenzini E; Corsini C; Tarella C; Gianni AM; Rambaldi A; Cesano A; Pileri SA;

Early chemotherapy intensification with escalated BEACOPP in advanced-stage Hodgkin lymphoma with a positive interim PET-CT after 2 ABVD cycles: Long-term results of the GITIL/FIL HD 0607 trial in Haematologica

2017
AO Ordine Mauriziano

Gallamini A; Rossi A; Patti K; Picardi M; Romano A; Cantonetti M; La Nasa G; Trentin L; Bolis S; Rapezzi D; Viviani S; Gianni AM; Zoli V; Gottardi D; Tarella C; Gavarotti P; Corradini P; Cimminiello M; Schiavotto C; Parvis G; Zanotti R; Gini G; Ferreri AJ; Viero P; Miglino M; Billio A; Avigdor A; Prosperini G; Bergesio F; et alii...

Randomized Trial Comparing R-CHOP Versus High-Dose Sequential Chemotherapy in High-Risk Patients With Diffuse Large B-Cell Lymphomas. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2016 Nov 20;34(33):4015-4022. doi: 10.1200/JCO.2016.67.2980. Epub 2016 Oct 31.

2016
AO Cuneo
AOU Città della Salute di Torino
AO Ordine Mauriziano

Rambaldi A; Boschini C; Delaini F; Masciulli A; Pileri S; Tabanelli V; Bruna R; Chilosi M; Falorio S; Flenghi L; Frezzato M; Trentin L; Gini G; La Nasa G; Benedetti F; Ferreri AJ; Di Raimondo F; Castellino C; Negri G; Piccin A; Billio A; Zoli V; Zanni M; Mulé A; Corradini P; Patti C; Di Nicola M; Gritti G; Rossi A; et alii...

Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter Study. in International journal of radiation oncology, biology, physics / Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):783-91. doi: 10.1016/j.ijrobp.2015.12.019. Epub 2015

2016
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Ruella M; Filippi AR; Bruna R; Di Russo A; Magni M; Caracciolo D; Passera R; Matteucci P; Di Nicola M; Corradini P; Parvis G; Gini G; Olivieri A; Ladetto M; Ricardi U; Tarella C; Devizzi L;

Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma. in Clinical radiology / Clin Radiol. 2016 Mar;71(3):271-9. doi: 10.1016/j.crad.2015.11.018. Epub 2015 Dec 31.

2016
AO Ordine Mauriziano

Balbo-Mussetto A; Cirillo S; Bruna R; Gueli A; Saviolo C; Petracchini M; Fornari A; Lario CV; Gottardi D; De Crescenzo A; Tarella C;

Sequential therapy and risk-stratification in PTLD: Pooled analysis of 222 patients treated in the prospective, international, multicentric PTLD-1 trials in Transplantation

2016
AO Ordine Mauriziano

Trappe R; Dierickx D; Zimmermann H; Morschhauser F; Mollee P; Zaucha JM; Dreyling M; Dührsen U; Reinke P; Verhoef G; Subklewe M; Hüttmann A; Tousseyn T; Salles G; Kliem V; Hauser IA; Tarella C; Van Den Neste E; Anagnostopoulos I; Riess H; Leblond V; Choquet S;

The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations. in Blood / Blood. 2015 Jan 22;125(4):600-5. doi: 10.1182/blood-2014-05-576157. Epub 2014 Dec 12.

2015
AO Ordine Mauriziano

Bodini M; Ronchini C; Giacò L; Russo A; Melloni GE; Luzi L; Sardella D; Volorio S; Hasan SK; Ottone T; Lavorgna S; Lo-Coco F; Candoni A; Fanin R; Toffoletti E; Iacobucci I; Martinelli G; Cignetti A; Tarella C; Bernard L; Pelicci PG; Riva L;

Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation guidelines for the management of indolent, nonfollicular B-cell lymphoma (marginal zone, lymphoplasmacytic, and small lymphocytic lymphoma). in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2015 Feb;15(2):75-85. doi: 10.1016/j.clml.2014.07.002. Epub 2014 Jul 15.

2015
ASL Asti
AO Ordine Mauriziano
AOU Città della Salute di Torino
ASL Vercelli

Vitolo U; Rambaldi A; Marchetti M; Billio A; Barosi G; Baldini L; Arcaini L; Tarella C; Zinzani PL; Tura S;

High doses of antimetabolites followed by high-dose sequential chemoimmunotherapy and autologous stem-cell transplantation in patients with systemic B-cell lymphoma and secondary CNS involvement: Final results of a multicenter phase II trial in Journal of Clinical Oncology

2015
AO Ordine Mauriziano

Ferreri AJM; Donadoni G; Cabras MG; Patti C; Mian M; Zambello R; Tarella C; Di Nicola M; D'Arco AM; Doa G; Bruno-Ventre M; Assanelli A; Foppoli M; Citterio G; Fanni A; Mulè A; Caligaris-Cappio F; Ciceri F;

Life expectancy in follicular lymphoma is mainly determined by response to first LINE treatment: A LONG-TERM survey on 597 patients in Blood

2015
AO Ordine Mauriziano

Tarella C; Gueli A; Delaini F; Barbui AM; Bruna R; Caracciolo D; Gottardi D; Gritti G; Passera R; Ramadan S; Rossi A; Rambaldi A;

International prognostic index, type of transplant and response to rituximab are key parameters to tailor treatment in adults with cd20-positive b cell ptld: Clues from the ptld-1 trial in American Journal of Transplantation

2015
AO Ordine Mauriziano

Trappe RU; Choquet S; Dierickx D; Mollee P; Zaucha JM; Dreyling MH; Dührsen U; Tarella C; Shpilberg O; Sender M; Salles G; Morschhauser F; Jaccard A; Lamy T; Reinke P; Neuhaus R; Lehmkuhl H; Horst HA; Leithäuser M; Schlattmann P; Anagnostopoulos I; Raphael M; Riess H; Leblond V; Oertel S;

Cytokine-induced killer cells engineered with exogenous t-cell receptors directed against melanoma antigens: Enhanced efficacy of effector cells endowed with a double mechanism of tumor recognition in Human Gene Therapy

2015
AO Ordine Mauriziano

Elia AR; Circosta P; Sangiolo D; Bonini C; Gammaitoni L; Mastaglio S; Genovese P; Geuna M; Avolio F; Inghirami G; Tarella C; Cignetti A;

High doses of antimetabolites followed by high-dose sequential chemoimmunotherapy and autologous stem cell transplant in patients with systemic b-cell lymphoma and secondary central nervous system involvement: Final results of a multicenter Phase II trial in Haematologica

2015
AO Ordine Mauriziano

Bruno-Ventre M; Doa G; D'Arco AM; Di Nicola M; Tarella C; Zambello R; Mian M; Patti C; Cabras MG; Citterio G; Foppoli M; Ferreri AJM; Fanni A; Mulè A; Calimeri T; Ciceri F; Caligaris-Cappio F; Sassone M; Scarfò L;

Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma. in Leukemia / Leukemia. 2014 Sep;28(9):1885-91. doi: 10.1038/leu.2014.79. Epub 2014 Feb 20.

2014
AO Ordine Mauriziano
AO Cuneo
AOU Alessandria

Pileri S; Dodero A; Tarella C; Ferreri A; Patti C; Baldini L; Bruno B; Salvi F; Todeschini G; Rossi G; Benedetti F; Olivieri A; Gallamini A; Patriarca F; Miceli R; Rambaldi A; Corradini P; Vitolo U;

Rate of primary refractory disease in B and T-cell non-Hodgkin's lymphoma: correlation with long-term survival. in PloS one / PLoS One. 2014 Sep 25;9(9):e106745. doi: 10.1371/journal.pone.0106745. eCollection 2014.

2014
AO Ordine Mauriziano
AOU Città della Salute di Torino

Tarella C; Gueli A; Delaini F; Rossi A; Barbui AM; Gritti G; Boschini C; Caracciolo D; Bruna R; Ruella M; Gottardi D; Passera R; Rambaldi A;

High doses of antimetabolites followed by high-dose sequential chemoimmunotherapy and autologous stem cell transplant in systemic B-cell lymphomas with CNS involvement: A multicenter phase II trial in Haematologica

2014
AO Ordine Mauriziano

Caligaris-Cappio F; Ciceri F; Mulè A; Pinotti G; Bruno Ventre M; Foppoli M; Fanni A; Di Nicola M; D'Arco AM; Doa G; Zambello R; Tarella C; Cabras MG; Patti C; Milan M; Ferreri AJ; Donadoni G;

Whole body magnetic resonance imaging with diffusion weighted imaging is a valuable alternative to contrast-enhanced computed tomography for the initial staging in Hodgkin's and non-Hodgkin's lymphoma in Blood

2014
AO Ordine Mauriziano

Balbo-Musetto A; Bruna R; Gueli A; Saviolo C; Petracchini M; Gottardi D; De Crescenzo A; Cirillo S; Tarella C;

Normal circulating B cells are markedly reduced in follicular lymphoma and diffuse large B cell lymphoma at diagnosis in Blood

2014
AO Ordine Mauriziano

Geuna M; Riccardo B; Cignetti A; Santoro N; Gueli A; Elia AR; Prato G; De Rosa G; Papotti M; Tarella C;

Long-term results of the phase III GITMO/FIL trial of CHOP-R versus R-HDS plus autograft in high-risk follicular lymphoma (FL) at diagnosis in Journal of Clinical Oncology

2014
AO Ordine Mauriziano

Magni M; Ladetto M; Gueli A; Passera R; Bruna R; Corradini P; Zoli V; Perrone T; Stelitano C; Rossini F; Castellino C; Gini G; Liberati AM; Musso M; Pulsoni A; Barbui AM; Patti C; Boccomini C; Benedetti F; Tarella C;

Feasibility and efficacy of high doses of antimetabolites followed by high-dose sequential chemoimmunotherapy (R-HDS) and autologous stem cell transplant (ASCT) in patients (pts) with systemic B-cell lymphoma (BCL) and central nervous system (CNS) involvement: A multicenter phase II trial in Journal of Clinical Oncology

2014
AO Ordine Mauriziano

Caligaris-Cappio F; Ciceri F; Foppoli M; Fanni A; Doa G; Mulè A; Tarella C; Di Nicola MA; D'Arco A; Ventre MB; Mian M; Zambello R; Cabras MG; Patti C; Ferreri AJM; Donadoni G;

Multiple courses of G-CSF in patients with decompensated cirrhosis: consistent mobilization of immature cells expressing hepatocyte markers and exploratory clinical evaluation. in Hepatology international / Hepatol Int. 2013 Oct;7(4):1075-83. doi: 10.1007/s12072-013-9473-9. Epub 2013 Oct 11.

2013
AO Ordine Mauriziano
AOU Città della Salute di Torino

Gaia S; Olivero A; Smedile A; Ruella M; Abate ML; Fadda M; Rolle E; Omedè P; Bondesan P; Passera R; Risso A; Aragno M; Marzano A; Ciancio A; Rizzetto M; Tarella C;

Telomere shortening in Ph-negative chronic myeloproliferative neoplasms: A biological marker of polycythemia vera and myelofibrosis, regardless ofhydroxycarbamide therapy in Experimental Hematology

2013
AO Ordine Mauriziano

Sivera P; Ricca I; Barbui T; Spatola T; Buttiglieri S; Carobbio A; Risso A; Salmoiraghi S; Ruella M; Tarella C; Rambaldi A;

Bone marrow-derived cell mobilization by G-CSF to enhance osseointegration of bone substitute in high tibial osteotomy in Knee Surgery, Sports Traumatology, Arthroscopy

2013
AO Ordine Mauriziano

Tron A; Borrè A; Blonna D; Tarella C; Ruella M; Risso A; Marenco S; Rossi R; Castoldi F; Marmotti A;

Successful second autologous engraftment after long duration storage of hematopoietic stem cells in Bone Marrow Transplantation

2013
AO Ordine Mauriziano

Longoni P; Milanesi M; Di Nicola M; Devizzi L; Carrabba M; Arienti F; Ravagnani F; Tarella C; Montefusco V; Gianni A; Corradini P; Magni M;

Long-term results of autologous hematopoietic stem-cell transplantation after high-dose90Y-ibritumomab tiuxetan for patients with poor-risk non-Hodgkin lymphoma not eligible for high-dose BEAM in Journal of Clinical Oncology

2013
AO Ordine Mauriziano

Gianni AM; Bombardieri E; Cox MC; Chiesa C; Carlo-Stella C; Ruella M; Viviani S; Matteucci P; Tarella C; Di Nicola M; Testi A; Magni M; Maccauro M; Passera R; Seregni E; Guidetti A; Devizzi L;

Intensified program including bendamustine, high dose therapy and autograft for patients with relapsed or resistant follicular non hodgkin lymphoma: Results from an exploratory gitil study in Hematological Oncology

2013
AO Ordine Mauriziano

Patti C; Mule' A; Barbui A; Tringali S; Costa A; Gueli A; Castellino C; Magni M; Dodero A; Leone M; Fabbiano F; Gallamini A; Corradini P; Gianni A; Tarella C; Rambaldi A; Scime' R;

Efficacy of rituximab-bendamustine in cold agglutinin haemolytic anaemia refractory to previous chemo-immunotherapy: A case report in Blood Transfusion

2013
AO Ordine Mauriziano

Tarella C; De Crescenzo A; Ricca I; Hu H; Gottardi D; Gueli A;

Haploidentical cellular therapy in elderly patients with acute myeloid leukemia: Description of its use in high risk patients in American Journal of Hematology

2013
AOU Città della Salute di Torino
AO Ordine Mauriziano

Cignetti A; Ruella M; Elia A; Tassi V; Redoglia V; Gottardi D; Tarella C;

The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapy in American Journal of Hematology

2013
AO Ordine Mauriziano

Rambaldi A; Boschini C; Gritti G; Delaini F; Oldani E; Rossi A; Barbui AM; Caracciolo D; Ladetto M; Gueli A; De Crescenzo A; Passera R; Devizzi L; Patti C; Gianni AM; Tarella C;

Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma in Annals of Hematology

2013
AO Ordine Mauriziano

Ferrero S; Monitillo L; Mantoan B; Barbero D; Genuardi E; Barbiero S; Bernocco E; Caracciolo D; Ruella M; Drandi D; Zanni M; Renna F; Lobetti Bodoni C; Gueli A; Passera R; Musto P; Boccadoro M; Tarella C; Ladetto M;

Potent in vivo anti-tumor activity of extracellular vesicles isolated from genetically engineered primary mesenchymal stromal cells expressing the trans-membrane TNF-related apoptosis-inducing ligand (TRAIL) in Blood

2013
AO Ordine Mauriziano

Buttiglieri S; Carlo-Stella C; Spatola T; Pulito R; Naldini L; Anichini A; Magni M; Giacomini A; Tarella C; Gianni AM;

The lymphocytes to monocytes ratio identifies a patient subgroup among high risk DLBCL that may benefit from upfront intensive treatment with autograft in Haematologica

2013
AO Ordine Mauriziano

Barbui AM; Masciulli A; Scarano M; Delaini F; Rossi A; Ladetto M; Corradini P; Di Nicola M; Patty C; Mulè A; Zanni M; Zoli V; Billio A; Gallamini A; Di Raimondo F; Ferreri AJM; Benedetti F; Leoni P; Semenzato G; Frezzato M; Flenghi L; Marchioli R; Barbui T; Gianni AM; Tarella C; Cortelazzo S; Rambaldi A;

Frequency and clinical outcome of primary refractory disease in nonhodgkin's lymphoma: A retrospective survey on 3,492 newly diagnosed patients undergoing first-line chemotherapy in Haematologica

2013
AO Ordine Mauriziano

Tarella C; Gueli A; Delaini F; Rossi A; Barbui A; Gritti G; Caracciolo D; Hu H; Gottardi D; Passera R; Rambaldi A;

Telomere loss is an early and persistent abnormality in leukocytes from patients treated with conventional chemotherapy but not from those exposed to rituximab alone in Haematologica

2013
AO Ordine Mauriziano

Gueli A; Risso A; Spatola T; Hu H; Gottardi D; De Crescenzo A; Buttiglieri S; Tarella C;

Telomere analysis shows that hematopoiesis in recipients of umbilical cord blood is biologically younger compared to the age-matched healthy population in Haematologica

2013
AO Ordine Mauriziano

Tarella C; Risso A; Spatola T; Ruella M; Milone G; Pioltelli P; Iori AP; Di Bartolomeo P; Rambaldi A; Bacigalupo A; Arcese W;

Lymphocyte transformation and autoimmune disorders in Autoimmunity Reviews

2013
AO Ordine Mauriziano

Tarella C; Gueli A; Ruella M; Cignetti A;

Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups in Blood Cancer Journal

2013
AO Ordine Mauriziano

Riva L; Ronchini C; Bodini M; Lo-Coco F; Lavorgna S; Ottone T; Martinelli G; Iacobucci I; Tarella C; Cignetti A; Volorio S; Bernard L; Russo A; Melloni GEM; Luzi L; Alcalay M; Dellino GI; Pelicci PG;

Use of the novel thrombopoietin receptor-agonist romiplostim, in combination with steroids and immunoglobulins for the increase of platelets prior to splenectomy, in refractory immune thrombocytopenia: A case report in Blood Coagulation and Fibrinolysis

2012
AO Ordine Mauriziano

Wade M; Tarella C; Hu H; Gueli A; Ruella M; Sivera P;

Primary refractory disease in non-Hodgkin's lymphoma: A retrospective study on 3,952 newly diagnosed patients undergoing first-line chemotherapy in Blood

2012
AO Ordine Mauriziano

Tarella C; Gueli A; Delaini F; Rossi A; Barbui AM; Gritti G; Caracciolo D; Hu H; Gottardi D; Passera R; Rambaldi A;

The peripheral blood lymphocyte to monocyte ratio at diagnosis is a potent outcome predictor in diffuse large B-cell lymphoma treated with R-CHOP: A long-term analysis on 973 patients receiving chemotherapy with or without rituximab in Blood

2012
AO Ordine Mauriziano

Rambaldi A; Boschini C; Delaini F; Oldani E; Rossi A; Barbui AM; Gritti G; Caracciolo D; Ladetto M; Gueli A; De Crescenzo A; Passera R; Devizzi L; Gianni AM; Tarella C;

Molecular and functional analysis of peripheral lymphocytes in churg strauss syndrome reveals several monoclonal expansions of CD8+ cells with a Th1/proinflammatory profile in Blood

2012
AO Ordine Mauriziano

Boita M; Circosta P; Guida G; Elia AR; Heffler E; Geuna M; Tarella C; Rolla G; Cignetti A;

Intensified chemo-immunotherapy including up-front autologous or allogeneic stem cell transplantation (SCT) for young patients with newly diagnosed peripheral T-cell lymphomas: Final results of a phase II multicenter prospective clinical trial in Blood

2012
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Corradini P; Vitolo U; Rambaldi A; Miceli R; Patriarca F; Gallamini A; Olivieri A; Benedetti F; Todeschini G; Rossi G; Parvis G; Salvi F; Bruno B; Baldini L; Patti C; Milone G; Ferreri AJM; Tarella C; Pileri SA; Dodero A;

Long telomere length of white blood cells following umbilical cord blood transplant (UCBT): Is hematopoiesis younger in UCBT recipients compared to healthy age-matched controls? in Blood

2012
AO Ordine Mauriziano

Tarella C; Risso A; Spatola T; Ruella M; Milone G; Pioltelli P; Iori AP; Di Bartolomeo P; Rambaldi A; Bacigalupo AP; Arcese W;

Circulating non-leukemic b cells and b cell subsets are altered in B cell non-hodgkin lymphoma patients in Cytometry Part B - Clinical Cytometry

2012
AO Ordine Mauriziano

Geuna M; Prato G; Santoro N; Gueli A; Tarella C; Cignetti A;

A short course of granulocytecolony-stimulating factor to accelerate wound repair in patients undergoing surgery for sacrococcygeal pilonidal cyst: Proof of concept in Cytotherapy

2012
AO Ordine Mauriziano

Tarella C; Omedè P; Passera R; Monni M; Scuderi S; Ruella M; Baldelli CMF;

Addition of rituximab to involved-field radiotherapy prolongs progression free survival in stage I-II follicular lymphomas: A multicentric, retrospective survey in Haematologica

2012
AO Ordine Mauriziano

Ruella M; Filippi A; Di Russo A; Matteucci P; Caracciolo D; Passera R; Magni M; Di Nicola M; Montefusco V; Parvis G; Gini G; Ladetto M; Ricardi U; Tarella C; Gianni AM; Devizzi L;

Cell-therapy with HLA-mismatched mobilized peripheral blood stem cells after standard chemotherapy in elderly patients with acute myeloid leukemia: Preliminary data on feasibility and safety in Haematologica

2012
AO Ordine Mauriziano
AOU Città della Salute di Torino

Cignetti A; Ruella M; Hu H; Elia A; Tassi V; Redoglia V; Gottardi D; Tarella C;

Early and persistent telomere shortening in leukocytes from patients treated with conventional chemotherapy but not from those exposed to rituximab alone in Haematologica

2012
AO Ordine Mauriziano

Gueli A; Risso A; Ruella M; Spatola T; Hu H; Gottardi D; De Crescenzo A; Buttiglieri S; Tarella C;

Role of whole body magnetic resonance including diffusion weighted imaging in the initial staging of lymphoma in Haematologica

2012
AO Ordine Mauriziano

Tarella C; Cirillo S; Hu H; Gueli A; Ruella M; Petracchini M; Gottardi D; Lario C; De Crescenzo A; Balbo-Mussetto A; Saviolo C;

Pre-emptive rituximab-based treatment of molecular relapses in follicular and mantle cell lymphoma in Haematologica

2012
AO Ordine Mauriziano

Ferrero S; Monitillo L; Mantoan B; Barbero D; Genuardi E; Bruna R; Bernocco E; Caracciolo D; Ruella M; Drandi D; Zanni M; Gueli A; Renna F; Ghione P; Lobetti Bodoni C; Barbiero S; Musto P; Boccadoro M; Tarella C; Ladetto M;

Short course of granulocyte-colony stimulating factor to accelerate wound repair in patients undergoing surgery for sacro-coccygeal pilonidal cyst: Proof of concept in Haematologica

2012
AO Ordine Mauriziano

Ruella M; Fronticelli CM; Scuderi S; Monni M; Passera R; Omede' P; Tarella C;

Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: An analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo in Bone Marrow Transplantation

2012
ASL Asti
AO Ordine Mauriziano

Olivieri A; Marchetti M; Lemoli R; Tarella C; Iacone A; Lanza F; Rambaldi A; Bosi A;

High-dose sequential chemoimmunotherapy supported by autologous stem cell transplantation in patients with systemic B-cell lymphoma and central nervous system involvement: Interim analysis of a multicentre phase II Trial in Bone Marrow Transplantation

2011
AO Ordine Mauriziano

Marturano E; Patti C; Cabras MG; Cortelazzo S; Zambello R; Carrabba M; Mule A; Peccatori J; Ciceri F; Tarella C; Ferreri AJ;

The aging effect of chemotherapy on cultured human mesenchymal stem cells in Experimental Hematology

2011
AO Ordine Mauriziano

Buttiglieri S; Ruella M; Risso A; Spatola T; Silengo L; Avvedimento EV; Tarella C;

Rituximab followed by involved fields radiotherapy (IF-RT) in stage I-II follicular lymphoma (FL): Long term results in Blood

2011
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ruella M; Filippi A; Russo ADI; Caracciolo D; Matteucci P; Magni M; Di Nicola M; Ricardi U; Montefusco V; Parvis G; Tarella C; Gianni AM; Devizzi L;

Early and permanent telomere shortening in bone marrow-derived cells following chemotherapy: A parallel study in vivo in lymphoma patients and in vitro in cultured mesenchymal stem cells in Blood

2011
AO Ordine Mauriziano

Gueli A; Ruella M; Risso A; Spatola T; Hu HJ; Gottardi D; De Crescenzo A; Buttiglieri S; Tarella C;

Safety, tolerability and activity of ofatumumab, bendamustine and dexamethasone combination as first-line treatment of mantle-cell lymphoma in the elderly: A multicenter study in Blood

2011
AO Ordine Mauriziano

Magni M; Di Nicola M; Carlo-Stella C; Devizzi L; Guidetti A; Matteucci P; Viviani S; Zambelli S; Ferreri AJM; Rambaldi A; Di Raimondo F; Tarella C; Gallamini A; Nobile F; Vallisa D; Carella AM; Patti C; Quarta G; Rizzoli V; Benedetti F; Corradini P; Gianni AM;

Retargeting of citokine-induced killer (CIK) cells with molecularly engrafted T-cell receptors (TCR): A preclinical in vitro and in vivo study in Blood

2011
AO Ordine Mauriziano

Elia AR; Inghirami G; Circosta P; Cristofani F; Santoro N; Sangiolo D; Tarella C; Cignetti A;

Pre-operative cytokine-induced mobilization of bone marrow-derived cells, followed by revascularization surgery: Early and long-term results of a prospective study in patients with end-stage ischemic cardiac disease in Blood

2011
AO Ordine Mauriziano

Actis Dato GM; Sansone F; Zingarelli E; Flocco R; Punta G; Parisi F; Forsennati PG; Bardi GL; Ponte SD; Casabona R; Tarella C;

Retargeting of citokine-induced killer (CIK) cells with molecularly engrafted T-cell receptors (TCR): A preclinical study in Haematologica

2011
AO Ordine Mauriziano

Elia A; Circosta P; Geuna M; Sangiolo D; Tarella C; Cignetti A;

Efficacy of lenalidomide as single agent to control minimal residual disease in chronic lymphocytic leukemia in first complete remission in Haematologica

2011
AO Ordine Mauriziano

Ruella M; De Crescenzo A; Gottardi D; Prato G; Geuna M; Gueli A; Tarella C;

Telomere shortening is an early aging sign following exposure to cytotoxic drugs: Assessment both in vitro on cultured mesenchymal stem cells and in vivo on cells from patients undergoing chemotherapy in Haematologica

2011
AO Ordine Mauriziano

Risso A; Buttiglieri S; Gueli A; Spatola T; Avvedimento EV; De Crescenzo A; Gottardi D; Mezzabotta M; Ruella M; Tarella C;

Pre-operative bone marrow-derived cell mobilization by G-CSF (granulocyte-colony stimulating factor) enhances osseointegration of bone substitute in patients undergoing surgery with high tibial valgus osteotomy in Haematologica

2011
AO Ordine Mauriziano

Tarella C; Rossi P; Borrè A; Ruella M; Risso A; Marenco S; Giacalone F; Tron A; Rossi R; Castoldi F; Marmotti A;

Reply: Too much, too soon? in Muscle and Nerve

2011
AO Ordine Mauriziano

Chió A; Tarella C;

Accelerated telomere shortening is an early and permanent signature in cultured human mesenchymal stem cells exposed to chemotherapy in Haematologica

2011
AO Ordine Mauriziano

Tarella C; Avvedimento V; Silengo L; Spatola T; Risso A; Ruella M; Buttiglieri S;

A CD8+ T-cell clone directed against AML blasts that recognizes a tumor specific antigen expressed also by solid tumors in Blood

2010
AO Ordine Mauriziano

Elia AR; Circosta P; Vincenzo R; Mele L; Allione B; Tarella C; Cignetti A;

Telomere length in Ph - Negative chronic myeloproliferative neoplasms: It is reduced according to JAK2 V617F mutation allele burden and it is not affected by cytoreductive treatment with hydroxyurea in Blood

2010
AO Ordine Mauriziano

Ruella M; Salmoiraghi S; Risso A; Carobbio A; Sivera P; Ricca I; Barbui T; Tarella C; Rambaldi A;

Telomere length is reduced in ph-negative chronic myeloproliferative neoplasms according to JAK2 V617F mutation allele burden but it is maintained in secondary erythrocytosis in Haematologica

2010
AO Ordine Mauriziano

Ruella M; Salmoiraghi S; Risso A; Carobbio A; Sivera P; Ricca I; Barbui T; Tarella C; Rambaldi A;

Exposure of cultured mesenchymal stem cells to chemotherapy: A simple and reliable procedure to investigate the molecular mechanisms of stem cell senescence in Haematologica

2010
AO Ordine Mauriziano

Avvedimento E; Tarella C; Tracchi S; Montanini M; Risso A; Ruella M; Spatola T; Buttiglieri S;

Feasibility, safety and therapeutic potential of systemic pre-operative bone marrow-derived cell mobilization by G-CSF to enhance osseointegration of bone substitute in high tibial osteotomy in Haematologica

2010
AO Ordine Mauriziano

Tarella C; Rossi P; Borrè A; Ruella M; Risso A; Realmuto C; Marenco S; Giacalone F; Tron A; Rossi R; Castoldi F; Marmotti A;

Generation of a T-cell clone directed against AML blasts that recognizes a tumor specific antigen expressed also by solid tumors in Haematologica

2010
AO Ordine Mauriziano

Elia A; Circosta P; Russo V; Mele L; Allione B; Tarella C; Cignetti A;

An allo-restricted peptide-specific CD8+ T-cell clone directed against the universal tumor antigen survivin in Haematologica

2010
AO Ordine Mauriziano

Circosta P; Elia A; Orso F; Tarella C; Cignetti A;

Telomere loss in ph- negative chronic myeloproliferative neoplasms: The role of JAK2 V617F mutation allele burden and the influence of the history of the illness in Haematologica

2010
AO Ordine Mauriziano

Ruella M; Salmoiraghi S; Risso A; Carobbio A; Sivera P; Mezzabotta M; Ricca I; Barbui T; Tarella C; Rambaldi A;

G-CSF-induced bone marrow-derived stem cells mobilization before sacrococcygeal pilonidal cyst surgery in Haematologica

2010
AO Ordine Mauriziano

Ruella M; Scuderi S; Monni M; Omedè P; Fronticelli Baldelli C; Tarella C;

Comparative assessment of telomere length before and after hematopoietic SCT: Role of grafted cells in determining post-transplant telomere status in Bone Marrow Transplantation

2010
AO Ordine Mauriziano

Ruella M; Rocci A; Ricca I; Carniti C; Bodoni CL; Ladetto M; Caracciolo D; Boccadoro M; Carlo-Stella C; Corradini P; Tarella C;

Male gender, quality of grafted cells, advanced age, rituximab and radiotherapy are the main factors that variously influence the occurrence of secondary malignancies following high-dose therapy and autograft: A GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) survey in 1,347 lymphoma patients in Blood

2009
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tarella C; Passera R; Magni M; Rossi A; Benedetti F; Gueli A; Patti C; Parvis G; Ciceri F; Gallamini A; Cortelazzo S; Corradini P; Zoli V; Mule A; Crocchiolo R; Bosa M; Barbui A; Di Nicola M; Caracciolo D; Sorio M; Gianni AM; Rambaldi A;

Dexamethasone, cytarabine and cisplatin or oxaliplatin schedule (DHAP or OX-DHA) is effective and widely applicable in chronic lymphocytic leukemia and waldenström macroglobulinemia in Blood

2009
AO Ordine Mauriziano

Ruella M; Ricca I; Gueli A; Gottardi D; Caracciolo D; Bergui L; Gavarotti P; De Crescenzo A; Farina L; Corradini P; Tarella C;

High response rate with favorable survival projections in high-risk patients with diffuse large B-cell lymphoma (DLBCL) receiving R-CHOP-14 or early intensified chemotherapy with rituximab and autograft (R-HDS): Results of the interim analysis of a gitil prospective multicenter phase III study in Blood

2009
AO Ordine Mauriziano

Cortelazzo S; Tarella C; Gianni AM; Ladetto M; Zanni M; Corradini P; Di Nicola M; Patti C; Mulè A; Majolino I; Billio A; Gueli A; Di Raimondo F; Chiarenza A; Gallamini A; Ferreri A; Pizzolo G; Benedetti F; La Nasa G; Leoni P; Gini G; Trentin L; Rodeghiero F; Marchioli R; Barbui T; Barbui A; Rambaldi A;

Preliminary results of a phase II trial with the multikinase inhibitor sorafenib in heavily pretreated patients with relapsed/refractory non-Hodgkin lymphoma (NHL) in Blood

2009
AO Ordine Mauriziano

Guidetti A; Carlo-Stella C; Devizzi L; Matteucci P; Marchianò A; Lanocita R; Magni M; Dodero A; Tarella C; Di Nicola M; Corradini P; Gianni AM;

The long-term outcome of high-risk follicular lymphoma patients receiving intensive therapy with autograft as primary treatment: Results from three consecutive prospective trials performed in Italy over the past 18 years in Haematologica

2009
AO Ordine Mauriziano

Corradini P; Gianni AM; Pileri A; Passera R; Ruella M; Ladetto M; Tarella C;

Factors influencing the occurrence of secondary myelodysplastic syndrome/acute leukemia following high-dose therapy and autograft: A GITIL (Gruppo Italiano Terapie innovative nei linfomi) survey in 1,347 lymphoma patients in Haematologica

2009
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tarella C; Passera R; Magni M; Rossi A; Gueli A; Benedetti F; Patti C; Parvis G; Ciceri F; Gallamini A; Cortelazzo S; Corradini P; Zoli V; Leone M; Bosa M; Barbui A; Di Nicola M; Boccadoro M; Sorio M; Gianni AM; Rambaldi A;

Limited stage low-grade lymphoma patients receiving Rituximab combined with localized radiotherapy: The long-term follow-up shows prolonged survival with low incidence of disease recurrence in Haematologica

2009
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tarella C; Caracciolo D; Ruella M; Bazzan M; Parvis G; Ladetto M; Boccadoro M; Mistretta A; Patti C; Todisco L; Franco P; Ricardi U; Filippi AR;

Modified DHAP schedule containing oxaliplatin (OX-DHA) is effective and widely applicable in Chronic Lymphocytic Leukemia and Waldestrom disease in Haematologica

2009
AO Ordine Mauriziano

Ricca I; Ruella M; Gueli A; Gottardi D; Caracciolo D; Bergui L; Gavarotti P; Boccadoro M; Tarella C;

Accelerated telomere shortening in Ph - Negative Chronic Myeloproliferative Neoplasms: Comparison with the healthy population and correlations with treatment received in Haematologica

2009
AO Ordine Mauriziano

Ruella M; Salmoiraghi S; Risso A; Sivera P; Barbui T; Rambaldi A; Tarella C;

Histology and rituximab addition are the main factors influencing the long-term outcome in high-risk lymphoma following high-dose therapy and autograft: A 20-yr. Follow-up in 1,347 patients by gitil (gruppo italiano terapie innovative NEI Linfomi) in Haematologica

2009
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tarella C; Di Nicola M; Rossi A; Caracciolo D; Passera R; Benedetti F; Patti C; Parvis G; Ciceri F; Castellino C; Cortelazzo S; Corradini P; Majolino I; Mule' A; Bosa M; Barbui A; Magni M; Boccadoro M; Sorio M; Rambaldi A; Gianni AM;